300009.SZ
300009.SZ
CNE100000GY2
ANKEBIO
Loading chart...

Company Profile

-

Related stocks

9606.HK
9606.HK • China
DUALITYBIO-B
182.7 HKD
2.13B USD 1Y -42.1%
9969.HK
9969.HK • China
INNOCARE
12.73 HKD
2.87B USD 1Y -23.4%
1877.HK
1877.HK • China
JUNSHI BIO
17.65 HKD
2.31B USD 1Y -40.6%
688166.SS
688166.SS • China
BRIGHTGENE BIO-MEDICAL TECHNOLO
33.53 CNY
2.19B USD 1Y -41.8%
300255.SZ
300255.SZ • China
CHANGSHAN PHARMA
22.15 CNY
3.05B USD 1Y -55.1%
300204.SZ
300204.SZ • China
STAIDSON BIO
20.66 CNY
1.67B USD 1Y -38.7%
2595.HK
2595.HK • China
GENFLEET-B
28.6 HKD
1.4B USD 1Y -21%
688105.SS
688105.SS • China
NANJING VAZYME BIOTECH CO LTD
26.6 CNY
2.06B USD 1Y +49.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
36.0% p.a.
Max Drawdown (5Y)
-46.7%
Sharpe Ratio (5Y)
-0.28
Beta Factor
0.37
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (36.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -60.3% in the extended horizon.
ende